Zivo Bioscience, Inc.
ZIVO· OTC
ZIVOZivo Bioscience, Inc.
Filed Feb 25, 2021 · 10-K · 56 days after period end · 0001078782-21-000172
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.89M | -$4.13M | -$3.10M | -$3.88M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 25, 2021 · 56 d after period end
